The novel therapy of this peptide represents a exciting development in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide313547.azzablog.com/42456667/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment